SCHEMBL7228448

SCHEMBL7228448

Cc1ccc(-c2nccc(Sc3ccnc(-c4ccc(C)c(C)c4N)c3[N+](=O)[O-])c2[N+](=O)[O-])c(N)c1C

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.35
TP53 P04637 1/20 0.35
LMNA P02545 5/20 0.34
MAPT P10636 5/20 0.33
TDP1 Q9NUW8 3/20 0.33
KDM4E B2RXH2 2/20 0.33
PKM P14618 1/20 0.33
CYP3A4 P08684 3/20 0.33
TSHR P16473 3/20 0.33
NOS3 P29474 1/20 0.32
NOS2 P35228 1/20 0.32
HTT P42858 3/20 0.32
KMT2A Q03164 2/20 0.32
MITF O75030 2/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
RECQL P46063 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7228253 0.85 CYP1A2 (0.34) ALDH1A1TP53LMNAMAPTTDP1
SCHEMBL7222699 0.69 NOS3 (0.36) NOS3NOS2
SCHEMBL7228451 0.68 ALDH1A1 (0.46) ALDH1A1LMNAMAPTTDP1KDM4E
SCHEMBL7228444 0.68 PDE7A (0.39) ALDH1A1LMNAMAPTCYP3A4TSHR
SCHEMBL3192684 0.65 ALDH1A1 (0.62) ALDH1A1TP53TDP1CYP3A4TSHR
SCHEMBL7226711 0.64 TSHR (0.33) ALDH1A1TDP1CYP3A4TSHRSMN1; SMN2
SCHEMBL29674727 0.63 NOS2 (0.50) ALDH1A1TP53LMNAMAPTTDP1
SCHEMBL204345 0.63 NOS2 (0.50) ALDH1A1TP53LMNAMAPTTDP1
SCHEMBL7228254 0.62 ALDH1A1 (0.38) ALDH1A1LMNAMAPTTDP1PKM
SCHEMBL377032 0.62 TSHR (0.55) ALDH1A1TP53MAPTTDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6583138-B1 Mediators or antagonists of the effects of histamine, leukotriene and the like; heterocyclic ring condensed benzothiazine compounds; inhibit the activation of the tyrosine kinase of 72 kDa EISAI CO., LTD. (JP) 2003-06-24 US disclosed
EP-1057830-A1 HETEROCYCLE-FUSED BENZOTHIAZINE DERIVATIVES Eisai Co., Ltd. (JP) 2000-12-06 EP disclosed